Orthoplastics to invest in new factory & create 100 jobs

Orthoplastics, a world leader in the development and supply of implantable-grade plastics used within the Orthopaedic sector, has announced plans to open an additional manufacturing facility in the UK.

The new building, set to open in February 2020, is expected to create around 100 new jobs in the coming years and will enable them to further increase its market capabilities with over £5 million of investment annually. The firm underlined that it was a significant move for the business in a rapidly advancing and innovative market and one that is fully supported by US parent company, Viant Inc.

Orthoplastics has announced it will be opening a new manufacturing facility in Lancashire that is expected to create 100 new jobs / Picture: Orthoplastics

The new facility in Rossendale, Lancashire will become a centre of excellence for the business and a launchpad for its extensive global growth plans, designed to ensure Orthoplastics becomes world-leader in polymeric solutions.

Mark Allen, Managing Director at Orthoplastics, said: “This significant investment underlines our belief that there is huge potential for innovation and growth within the Orthopaedic sector.  It is also the next step towards achieving our ambition of pioneering improved patient outcomes and the longevity of implantable medical devices. Joint replacement procedures such as HIP and knee surgeries are highly successful of course, but we are leading the way in the evolution of new concepts to improve these life-changing operations.”

“If the Orthopaedic sector is to grow and thrive, we must embrace new technologies and materials. Our vision and ambition for superior materials solutions perfectly represent how we are putting this strategy into practice with Viant globally.”

Mark Allen, added: “Innovation is at the heart of the future of UK manufacturing, and this factory will provide our customers with the confidence in our long-term investments strategy, whilst demonstrating our strategic partnership and commitment.”

Alton Shader, CEO at Viant, concluded: “We focus on providing end-to-end solutions for medical device OEMs. Our extensive materials expertise including metals, combined with our experience in engineering, manufacturing, assembly, packaging and sterilization, allows us to bring our customers’ medical technology solutions to market.”